Eton Pharmaceuticals’ (ETON) Buy Rating Reiterated at HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Eton Pharmaceuticals (NASDAQ:ETON – Free Report) in a research report released on Wednesday,Benzinga reports. The firm currently has a $33.00 price objective on the stock. Several other research firms also recently commented on ETON. Craig Hallum increased their target price on Eton Pharmaceuticals from $15.00 to […]
HC Wainwright reaffirmed their buy rating on shares of Eton Pharmaceuticals (NASDAQ:ETON – Free Report) in a research report released on Wednesday,Benzinga reports. The firm currently has a $33.00 price objective on the stock. Several other research firms also recently commented on ETON. Craig Hallum increased their target price on Eton Pharmaceuticals from $15.00 to […]
